Bustos, M. A., et al. Integrated Assessment of Circulating Cell-Free MicroRNA signatures in Plasma of Patients With Melanoma Brain Metastasis. Cancers 2020, 12, 1692; doi:10.3390/cancers12061692
Suda et. al. Heterogeneity in immune biomarker expression after acquisition of resistance to EGFR kirase inhibitors: Analysis of a case with small cell lung cancer transformation; J Thorac Oncol. 2017 Jun; 1216: 1015
Howard K., et al. A Cross Comparison of Technologies for the Detection of Immune System Related Gene Expression Signatures in Clinical FFPE Samples of Metastatic Prostate Cancer Patients. Poster session presented at: The American Association of Cancer Research 2017 Apr; Washington, DC.
Reinholz M., et al. Multi-Site Reproducibility and Analytic Accuracy of the HTG EdgeSeq Immuno-Oncology Assay. Poster session presented at: The Association for Molecular Pathology (AMP) Global, 2017 Apr; Berlin, Germany.
Knudsen E., et al. Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunological Markers. Clin Cancer Res. 2017 Aug 1;23(15):4429
Margolles Clark E., et al. Gene expression profiling of transplant formalin-fixed, paraffin-embedded biopsies: comparison of a custom TaqMan low density array and quantitative nuclease-protection assay. Hum Immunol. 2016 Sep;77(Suppl):74.
Reinholz M., et al. Gene Expression Measurement of Immuno-Oncology Targets in a Single FFPE Section Using a Novel Targeted Sequencing Assay. Cancer Res. July 15 2016;76(14 Suppl):abstr 2237.
Page last updated November 29, 2022